Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

Market Cap	4.26B
Revenue (ttm)	1.76B
Net Income (ttm)	272.96M
Shares Out	439.09M
EPS (ttm)	0.61
PE Ratio	16.05
Forward PE	13.24
Dividend	0.25 (2.57%)
Ex-Dividend Date	Mar 5, 2025

Volume	11,228,300
Average Volume	12,890,796
Open	9.84
Previous Close	9.84
Day's Range	9.69 - 9.92
52-Week Range	8.47 - 13.58
Beta	0.28
RSI	46.72
Earnings Date	Apr 29, 2025

About SHA:603998

Hunan Fangsheng Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers medicines in the form of tablets, capsules, and granules for the treatment of orthopedic, cardiovascular and cerebrovascular, anti-infection, pediatric, gynecological, respiratory system, traumatology, and other diseases. The company was founded in 2002 and is based in Changsha, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 1,686
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603998

Financial Performance

In 2023, SHA:603998's revenue was 1.63 billion, a decrease of -9.12% compared to the previous year's 1.79 billion. Earnings were 186.82 million, a decrease of -34.64%.